Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) [Phase 2]
Phase 2 trial evaluating rituximab for schizophrenia spectrum disorders has completed and results have been posted.
-
CLINICAL_TRIALS withdrawal · 2025-03-21Clinical Trial Update: Evaluation Study of New Compounds With Potential Use in Schizophrenia [Phase 1]
Phase 1 clinical trial evaluating new compounds for schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: The Effect of Illness Management Skill Training Applied to Patients With Schizophrenia [NA]
This clinical trial update reports on a study evaluating Illness Management Skill Training for patients with schizophrenia, with the trial s…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
A clinical trial update describing an integrated neurophysiological approach for the early detection of psychiatric disorders, with a focus …
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: The Effects of Mindfulness and Web-Based Physical Activity Program in Patients With Schizophrenia [NA]
The document provides an update on a completed clinical trial evaluating mindfulness and a web-based physical activity program in patients w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan [Phase 3]
A Phase 3 clinical trial evaluating the long-term safety and tolerability of SEP-363856 in Japanese patients with schizophrenia has been ter…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors [NA]
A completed clinical trial update from Northwestern University examining genetic risk factors in schizophrenia and schizoaffective disorder.
-
FDA approval · 2025-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for ZIPRASIDONE HYDROCHLORIDE, a generic form of ziprasidone, indicating appro…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: The Effect of Mindfulness-Based Psychoeducation Programme Given Individually to Schizophrenia Patients on Internalised Stigma and Healthy Lifestyle Behaviours [NA]
An ongoing clinical trial sponsored by Kastamonu University is evaluating an individual mindfulness-based psychoeducation program for schizo…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia [NA]
A clinical trial is studying whether transcranial direct current stimulation (tDCS) affects cannabis use disorder symptoms in individuals wi…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia [Phase 1]
Phase 1 PET study evaluating dopamine synthesis capacity in the whole striatum after 2 weeks of ralmitaront versus placebo in people with sc…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
A translational study investigating the role of glutamate and GABA systems in schizophrenia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]
A Phase 4 clinical trial assessing gamma-aminobutyric acid (GABA) function in psychosis has completed.
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Psychiatric Disorders in Child and Adolescent Offspring of Parents with Schizophrenia and Bipolar Disorders.
A clinical trial update describing a study of psychiatric disorders in children and adolescents who have parents with schizophrenia or bipol…
-
FDA approval · 2025-03-12FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Abilify Maintena (aripiprazole) by Otsuka America Pharmaceutical, Inc. The product is a long…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Karolinska Schizophrenia Project
Karolinska Institutet is recruiting for the Karolinska Schizophrenia Project (NCT06872463) to study schizophrenia and related psychotic feat…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients [NA]
A clinical trial update for a psychosocial skills–focused group psychoeducation program in schizophrenia patients, currently not yet recruit…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia [Phase 3]
An ongoing Phase 3 trial is evaluating a once-weekly formulation of brexpiprazole for acute schizophrenia and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: CRacking the HEterogeneity of Social Outcome Through Neuropsychophysiological Profiles
This clinical trial update describes a not-yet-recruiting study aiming to understand heterogeneity in social outcomes in schizophrenia by ex…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training [NA]
This completed Vanderbilt University trial compares virtual reality training for social skills in schizophrenia to cognitive training, with …
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Interventional Programs' Impact on Patients' Quality of Life and Functioning [NA]
Clinical trial update indicating an interventional study assessing the impact of programs on quality of life and functioning in schizophreni…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition
A clinical trial exploring the neural and behavioral bases of metacognition in schizophrenia with impaired insight has completed.
-
CLINICAL_TRIALS withdrawal · 2025-03-07Clinical Trial Update: How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia [NA]
The clinical trial evaluating a driving-related virtual reality tool to improve quality of life and social autonomy in schizophrenia has bee…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT) [NA]
Completed randomized controlled trial MERIT evaluated metacognitive and insight therapy for schizophrenia spectrum disorders; results have b…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Neural Biomarkers of Clozapine Response
A completed clinical trial from the University of Pittsburgh examining neural biomarkers associated with clozapine response in schizophrenia…